Mike Pellini
General Partner at S32
About
Former CEO of Foundation Medicine, which transformed cancer evaluation through genomic analysis and was acquired by Roche. He brings three decades of experience in personalized medicine and previously held leadership roles including President and COO at Clarient, which was acquired by GE Healthcare.
Investments
Board seats
MedCrypt Inc.TwinStrand Biosciences, Inc.
As listed on the firm's website.